DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/69sxpq/microarray_markets) has announced the addition of the "Microarray Markets" report to their offering.

Microarray technologies multiplex and miniaturize the analysis of tens of thousands of molecules for a variety of assays, including drug binding, molecular interactions, enzyme activity and pathway identification. These microarrays, which include DNA microarrays, protein microarrays, tissue microarrays, low complexity microarrays and carbohydrate microarrays, are excellent tools for gene expression profiling, biomarker profiling and diagnostics.

Pharmaceutical and biotechnology researchers use microarrays to streamline drug target identification, selection, validation and predictive testing. Rapid growth in the clinical research and diagnostic devices markets holds great potential for applications of microarray technology, including basic research, clinical trials and diagnostic devices.

This report describes the specific segment of the microarray market aimed at the analysis of proteins and DNA. It examines various microarray platforms and the technologies that are utilized in hospitals, clinics, commercial laboratories and research institutions to detect DNA and proteins for the purpose of drug discovery, disease diagnosis and disease monitoring. Detailed tables and charts with sales forecasts and marketshare data are also included.

Companies Mentioned:

- Affymetrix

- Agilent Technologies, Inc

- AyoxxA

- Bio-Rad Laboratories

See original here:
Research and Markets: Microarray Markets - 2013 Report Examines Companies that are Actively Developing and Marketing ...

Comments are closed.